To reach a different BlackRock site directly, please update your user type.
IBB
Equity
iShares Biotechnology ETF
NAV as ofOct 21, 2026
$$211.4952 WK: 153.93 - 216.92
1 Day NAV Change as ofOct 21, 2026
Increase $$0.98(0.46%)
NAV Total Return as ofOct 21, 2026
YTD: Increase 25.41%
30 Day SEC Yield as ofSep 30, 2026
-0.15%
12m Trailing Yield as ofSep 30, 2026
0.16%
Expense Ratio:Fees as stated in the prospectus
0.44%
Morningstar Rating
3 stars
Morningstar Medalist Rating
NAV as ofOct 21, 2026
$$211.4952 WK: 153.93 - 216.92
1 Day NAV Change as ofOct 21, 2026
Increase $$0.98(0.46%)
NAV Total Return as ofOct 21, 2026
YTD: Increase 25.41%
30 Day SEC Yield as ofSep 30, 2026
-0.15%
12m Trailing Yield as ofSep 30, 2026
0.16%
Expense Ratio:Fees as stated in the prospectus
0.44%
Morningstar Rating
3 stars
Morningstar Medalist Rating
The iShares Biotechnology ETF seeks to track an index that includes U.S.-listed equities in the biotechnology sector. The fund offers a way to express a focused view on companies engaged in the research and development of therapeutic treatments.